A probiotic that prevents obesity could be on the horizon. Bacteria that produce a therapeutic compound in the gut inhibit weight gain, insulin resistance and other adverse effects of a high-fat diet in mice, investigators have discovered. Regulatory issues must be addressed before moving to human studies, but the findings suggest that it may be possible to manipulate the bacterial residents of the gut -- the gut microbiota -- to treat obesity and other chronic diseases.